<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ofatumumab Studie 54]]></title><description><![CDATA[<p dir="auto">Ofatumumab Studie 54<br />
Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia Condition:  Chronic Lymphocytic Leukemia<br />
Intervention:  Drug: ofatumumab plus dexamethasone<br />
Last Updated Date: March 7, 2011</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448336/ofatumumab-studie-54</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 13:22:18 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448336.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 10 Mar 2011 15:10:49 GMT</pubDate><ttl>60</ttl></channel></rss>